4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-18-018221
SVP & Chief Operating Officer sold 220,144 shares at an average $99.27 ($21,854,265)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nicholson John SVP & Chief Operating Officer | 2018-03-06 | Sale | −120,000 | $98.29 | $11,794,800 | 267,657 | D: show line 1 in the form |
| Nicholson John SVP & Chief Operating Officer | 2018-03-07 | Sale | −100,144 | $100.45 | $10,059,465 | 167,513 | D: show line 2 in the form |
| Open-market sales · 220,144 sh · avg $99.27 · $21,854,265 | |||||||
Loading xslF345X03/doc4.xml…